期刊
DRUG DISCOVERY TODAY
卷 18, 期 1-2, 页码 43-49出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2012.07.013
关键词
-
资金
- NIH
- American Lebanese Syrian Associated Charities
- St Jude Children's Research Hospital (SJCRH)
The identification of potent spliceosome modulators that demonstrate antitumor activity indicates that this complex may be a target for drug development. Several natural products have been demonstrated to bind to the SF3b1 subunit of this macromolecule and these agents modulate alternative RNA splicing. In this article we describe their biological properties, discuss the validity of the spliceosome as a therapeutic target, and propose that alteration of alternative splicing represents a viable approach for inducing tumor-selective cytotoxicity.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据